Crossmark Global Holdings, Inc. Immunocore Holdings PLC Transaction History
Crossmark Global Holdings, Inc.
- $5.5 Billion
- Q1 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 38,147 shares of IMCR stock, worth $1.38 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
38,147
Previous 38,020
0.33%
Holding current value
$1.38 Million
Previous $1.12 Million
0.89%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$254 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$221 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$176 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$96.6 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$83.8 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...